Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2A6 | P11509 | 5/20 | 0.48 |
| ▸ | CYP1A2 | P05177 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | HPRT1 | P00492 | 1/20 | 0.42 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.39 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.38 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.37 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.37 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.37 |
| ▸ | F12 | P00748 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31643929 | 0.87 | CYP1A2 (0.41) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL8207775 | 0.87 | CYP1A2 (0.41) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL30190041 | 0.85 | CYP2A6 (0.48) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL1131122 | 0.85 | CYP2A6 (0.48) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL2932475 | 0.85 | CYP2A6 (0.48) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL8768022 | 0.82 | CYP2A6 (0.42) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL17966499 | 0.81 | CYP2A6 (0.44) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL10319492 | 0.81 | CYP2A6 (0.44) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL8216176 | 0.81 | CYP2A6 (0.44) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR | |
| SCHEMBL15067611 | 0.80 | CYP2A6 (0.38) | CYP2A6CYP1A2ALDH1A1HSD17B10TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 51 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0880549-A2 | CATALYST SYSTEM AND COMPONENTS | EXXON CHEMICAL PATENTS INC. (US) | 1998-12-02 | — | — | EP | claimed |
| WO-1997030096-A2 | CATALYST SYSTEM AND COMPONENTS | EXXON CHEMICAL PATENTS INC. (US) | 1997-08-21 | — | — | WO | claimed |
| EP-3039080-B1 | CURABLE SILICONE COMPOSITION, CURED PRODUCT THEREOF, AND OPTICAL SEMICONDUCTOR DEVICE | DUPONT TORAY SPECIALTY MATERIALS KK (JP) | 2022-05-11 | — | — | EP | disclosed |
| CN-113214651-A | Curable silicone composition, cured product thereof, and optical semiconductor device | 杜邦东丽特殊材料株式会社 | 2021-08-06 | — | — | CN | disclosed |
| US-20210036245-A1 | HETEROAROMATIC COMPOUNDS | MERCK PATENT GMBH (DE) | 2021-02-04 | — | — | US | disclosed |
| CN-107223127-B | Method for producing organohalosilanes | 美国陶氏有机硅公司 | 2020-09-11 | — | — | CN | disclosed |
| EP-3253770-B1 | METHOD OF PRODUCING ORGANOHALOSILANES | DOW SILICONES CORP (US) | 2020-09-02 | — | — | EP | disclosed |
| EP-3253771-B1 | METHOD OF PRODUCING ORGANOHALOSILANES | DOW SILICONES CORP (US) | 2020-08-12 | — | — | EP | disclosed |
| CN-107206355-B | Method for producing organohalosilanes | 美国陶氏有机硅公司 | 2020-07-07 | — | — | CN | disclosed |
| US-20190263841-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | MERCK PATENT GMBH (DE) | 2019-08-29 | — | — | US | disclosed |
| US-10336913-B2 | Curable silicone composition, cured product thereof, and optical semiconductor device | DOW CORNING TORAY CO., LTD. (JP) | 2019-07-02 | — | — | US | disclosed |
| EP-1143538-A1 | Silacyclopentadiene derivatives and an organic electroluminescent element obtained by using the silacyclopentadiene derivative | Chisso Corporation (JP) | 2001-10-10 | — | — | EP | disclosed |
| US-6051319-A | Silacyclopentadiene derivatives and an organic electroluminescent element obtained by using the silacyclopentadiene derivative | CHISSO CORPORATION (JP) | 2000-04-18 | — | — | US | disclosed |
| US-5986121-A | Silacyclopentadiene derivatives and an organic electroluminescent element obtained by using the silacyclopentadiene derivative | CHISSO CORPORATION (JP) | 1999-11-16 | — | — | US | disclosed |
| EP-0617044-B1 | Process for preparing cyclopentadienyl group-containing silicon compound or cyclopentadienyl group-containing germanium compound | MITSUI CHEMICALS INC (JP) | 1999-01-20 | — | — | EP | disclosed |
| EP-0880549-A2 | CATALYST SYSTEM AND COMPONENTS | EXXON CHEMICAL PATENTS INC. (US) | 1998-12-02 | — | — | EP | disclosed |
| WO-1997030096-A2 | CATALYST SYSTEM AND COMPONENTS | EXXON CHEMICAL PATENTS INC. (US) | 1997-08-21 | — | — | WO | disclosed |
| EP-0754691-A2 | Silacyclopentadiene derivatives and an organic electroluminescent element obtained by using the silacyclopentadiene derivative | CHISSO CORPORATION (JP) | 1997-01-22 | — | — | EP | disclosed |
| US-5360921-A | REACTING LITHIUM, SODIUM OR POTASSIUM SALT OF A CYCLOPENTADIENE DERIVATIVE WITH A SILICON OR GERMANIUM HALIDE COMPOUND IN THE PRESENCE OF A CYANIDE OR A THIOCYANATE | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-11-01 | — | — | US | disclosed |
| EP-0617044-A2 | Process for preparing cyclopentadienyl group-containing silicon compound or cyclopentadienyl group-containing germanium compound | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-09-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190263841-A1 | COMPOUNDS FOR ELECTRONIC DEVICES | ETV6, EED, FES | CYP2A6 2210/4885CYP1A2 1050/4885ALDH1A1 636/4885 |
| US-20210036245-A1 | HETEROAROMATIC COMPOUNDS | ETV6, FES, LEF1 | CYP2A6 1117/4885CYP1A2 281/4885ALDH1A1 752/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.